EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial Effects of Dexmedetomidine and Midazolam in Bicarbonate Buffer: An in vitro Study

Özlem Kocatürk, Hicran Dönmez Özkan, Esin Poyrazoğlu Çoban, Halil Bıyık

Cerrahpaşa Medical Journal · 2019

DOI: 10.5152/cjm.2019.19011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerrahpaşa Medical Journal, 2019. Verfasst von Özlem Kocatürk und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dexmedetomidine and midazolam are commonly used sedatives, administered by infusion. The antibacterial properties of midazolam have been previously described. The aim of this in vitro study was to investigate the antimicrobial effects of dexmedetomidine, midazolam, and their solutions buffered with bicarbonate.

Methods

Using the disk diffusion and broth microdilution methods, antimicrobial efficacy was tested against Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Enterococcus faecalis (E. faecalis), Klebsiella pneumoniae (K. pneumoniae), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus epidermidis, Candida albicans, and Candida utilis.

Results

Dexmedetomidine showed an inhibitory effect on S. aureus, E. coli, E. faecalis, and P. aeruginosa at concentrations of ≥64 µg/mL and above. The antimicrobial effect of midazolam on S. aureus, E. coli, E. faecalis, K. pneumoniae, and P. aeruginosa was observed at concentrations ≥128 mg/mL. We further noted that the antimicrobial potency of dexmedetomidine increased with the addition of bicarbonate; however, this was not observed with midazolam.

Conclusion

We found that adding bicarbonate to dexmedetomidine may be beneficial in preventing bacterial contamination, especially when treating patients in intensive care. Similar to midazolam, dexmedetomidine showed antimicrobial properties against a subset of infectious microorganisms frequently encountered in a hospital environment. Our experiments indicate that the concentration-dependent antimicrobial efficacy of dexmedetomidine can be further enhanced by buffering with bicarbonate. Cite this article as: Kocatürk Ö, Dönmez Özkan H, Poyrazoğlu Çoban E, Bıyık H. Antimicrobial Effects of Dexmedetomidine and Midazolam in Bicarbonate Buffer: An in vitro Study. Cerrahpasa Med J 2019; 43(3): 69-74.

Zitieren

APA

Kocatürk, Ö., Özkan, H. D., Çoban, E. P., & Bıyık, H. (2019). Antimicrobial Effects of Dexmedetomidine and Midazolam in Bicarbonate Buffer: An in vitro Study. Cerrahpaşa Medical Journal. https://doi.org/10.5152/cjm.2019.19011

Vancouver

Kocatürk Ö, Özkan HD, Çoban EP, Bıyık H. Antimicrobial Effects of Dexmedetomidine and Midazolam in Bicarbonate Buffer: An in vitro Study. Cerrahpaşa Medical Journal. 2019. doi:10.5152/cjm.2019.19011

BibTeX
@article{Kocatrk2019,
  author = {Kocatürk, Özlem and Özkan, Hicran Dönmez and Çoban, Esin Poyrazoğlu and Bıyık, Halil},
  title = {Antimicrobial Effects of Dexmedetomidine and Midazolam in Bicarbonate Buffer: An in vitro Study},
  journal = {Cerrahpaşa Medical Journal},
  year = {2019},
  doi = {10.5152/cjm.2019.19011}
}
Kostenlos starten →